Memory Enhancing Drugs Market

Memory-Enhancing Drugs Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • July 2020
  • REP-GB-8713
  • PDF PPT EXCEL
Memory Enhancing Drugs Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Memory Enhancing Drugs market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Memory Enhancing Drugs market.

Memory-enhancing drugs are used for the treatment of diminished or decreased ability of person to memories due to traumatic injury to the central nervous system (CNS) or due to aging. The start of the memory loss or decreased cognition may result into the onset of the Alzheimer’s disease. Due to traumatic injury especially to the brain, brain cells tend to die and in case of aging person, although memory loss is common but it can be treated with memory-enhancing drugs. Although the market presence of regulatory authorities approved drugs for the memory enhancing drugs is limited but significant number of clinical trials are being carried out to study the outcome. Currently available memory enhancing drugs are mainly derived from food such as vitamins, antioxidants, lipids, etc. Some novel memory enhancing drugs are also approved in different parts of the world for the treatment. Use of off-label drugs like Ritalin and Adderall is increasing as memory-enhancing drugs.

Memory-Enhancing Drugs Market: Drivers and Restraints

The increasing prevalence of aging population and subsequently increasing prevalence of age related dementia expected to drive the growth of the memory-enhancing drugs market. The incidence of traumatic injuries are common and injury to CNS is often common resulting in decrease memorizing power of person, this can be treated with memory-enhancing drugs in turn driving the growth of the market.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

If the early symptoms of dementia or memory loss are not treated effectively then chances of developing Alzheimer’s disease increases hence early diagnosis of loss of cognition expected to drive the growth of the memory-enhancing drugs market. The significant number of the clinical trials going on in memory-enhancing drugs market and with marketing approval in few countries for the treatment of decreased ability to memories expected to fuel the growth of memory-enhancing drugs market. Although extended efforts on behalf of manufacturers are taken but reluctance in the general population to seek treatment in age related forgetfulness is very limited which in turn may hamper the potential market growth of memory-enhancing drugs.

Memory-Enhancing Drugs Market: Overview

The age related forgetfulness expected to serve as making of initial foothold for revenue generation in memory-enhancing drugs market in developing as well as developed countries. By the drug class, Smart Drugs and Cognitive Enhancers (Nootropics) segment expected to drive the growth of the memory-enhancing drugs market. By route of administration, oral segment expected to be most lucrative attributing to high patient convenience in the memory-enhancing drugs market. By distribution channel, retail pharmacies expected to be largest revenue generating segment due to higher patient footfall in the memory-enhancing drugs market. Manufacturers in the memory-enhancing drugs market are focusing on developing ‘smart drug’ for enhancing memory capacity and to overcome age related forgetfulness.

Memory-Enhancing Drugs Market: Regional Outlook

The global memory-enhancing drugs market is expected to be dominated by the North America due to higher treatment seeking rate in the early symptoms of Alzheimer’s disease as well as age related forgetfulness. Europe is expected to be second most lucrative memory-enhancing drugs market due to high prevalence of aging population. Asia-Pacific is expected to be emerging memory-enhancing drugs market due to increasing awareness about the available treatment options for the age related forgetfulness as well as traumatic injury-induced memory loss. Latin America memory-enhancing drugs market is expected to experience gradual growth due steadily increasing product penetration in the region. Middle East & Africa is expected to be least lucrative memory-enhancing drugs market due to least low treatment seeking rate as well as least product penetration.

Memory-Enhancing Drugs Market: Key Players

The key market players operating in the memory-enhancing drugs market are: Pfizer Inc., Johnson & Johnson, UCB S.A., Takeda Pharmaceutical Company, Shire plc., Sanochemia Pharmazeutika AG, Allergan plc., Novartis AG, Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd., and others.

The research report presents a comprehensive assessment of the Memory-Enhancing Drugs market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Memory-Enhancing Drugs market segments such as geographies, application, and industry.

The report covers exhaust analysis on: 

  • Memory-Enhancing Drugs Market Segments
  • Memory-Enhancing Drugs Market Dynamics
  • Memory-Enhancing Drugs Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Memory Enhancing Drugs Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Memory-Enhancing Drugs Market: Segmentation

The global memory-enhancing drugs market is segmented based on the by drug class, route of administration, distribution channel and region

By drug class the memory-enhancing drugs market is segmented as:

  • Cholinesterase Inhibitors
  • Smart Drugs and Cognitive Enhancers (Nootropics)
  • Vitamins and Supplements

By route of administration memory-enhancing drugs market is segmented as:

  • Oral
  • Injectable
  • Topical

By distribution channel memory-enhancing drugs market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Memory Enhancing Drugs Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Memory Enhancing Drugs Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients


Request Sample Request customization Request Methodology